Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.92
-0.17-4.03%
al cierre: -
$3.64
-0.28-7.26%
After hour: Oct 17, 7:39 AM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Clearside Biomedical Inc ha un obiettivo di prezzo di consenso pari a $5, stabilito in base alle ultime valutazioni degli analisti di 10. Le ultime 3 valutazioni degli analisti sono state rilasciate da HC Wainwright & Co., Needham y HC Wainwright & Co. il julio 18, 2025, julio 17, 2025 y mayo 23, 2025. Con un obiettivo di prezzo medio di $4.33 tra le HC Wainwright & Co., Needham y HC Wainwright & Co., c'è un implicito 19.05% upside per Clearside Biomedical Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
HC Wainwright & Co.
Needham
JMP Securities
Citizens Capital Markets
Oppenheimer
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Clearside Biomedical
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
07/18/2025 | — | Chardan Capital | — | Downgrade | Buy → Neutral | |||
07/18/2025 | 37.36% | HC Wainwright & Co. | $5 → $5 | Downgrade | Buy → Neutral | |||
07/17/2025 | -17.58% | Needham | → $3 | Downgrade | Buy → Hold | |||
05/23/2025 | 37.36% | HC Wainwright & Co. | $6 → $5 | Maintains | Buy | |||
05/16/2025 | 37.36% | JMP Securities | $5 → $5 | Reiterates | Market Outperform → Market Outperform | |||
05/15/2025 | -17.58% | Needham | $4 → $3 | Maintains | Buy | |||
04/08/2025 | 9.89% | Needham | $4 → $4 | Reiterates | Buy → Buy | |||
03/31/2025 | 64.84% | HC Wainwright & Co. | $6 → $6 | Reiterates | Buy → Buy | |||
03/28/2025 | 37.36% | Citizens Capital Markets | $5 → $5 | Reiterates | Market Outperform → Market Outperform | |||
03/28/2025 | 64.84% | Chardan Capital | $6 → $6 | Maintains | Buy | |||
03/28/2025 | 9.89% | Needham | $6 → $4 | Maintains | Buy | |||
03/06/2025 | 64.84% | Needham | $6 → $6 | Reiterates | Buy → Buy | |||
03/06/2025 | 64.84% | HC Wainwright & Co. | $6 → $6 | Reiterates | Buy → Buy | |||
11/15/2024 | 64.84% | Chardan Capital | $6 → $6 | Maintains | Buy | |||
11/14/2024 | 64.84% | HC Wainwright & Co. | $6 → $6 | Reiterates | Buy → Buy | |||
11/13/2024 | 64.84% | Needham | $6 → $6 | Reiterates | Buy → Buy | |||
10/14/2024 | 64.84% | Chardan Capital | $6 → $6 | Maintains | Buy | |||
10/10/2024 | 64.84% | Needham | $4 → $6 | Maintains | Buy | |||
08/27/2024 | 37.36% | HC Wainwright & Co. | $5 → $5 | Reiterates | Buy → Buy | |||
08/21/2024 | 64.84% | Chardan Capital | → $6 | Initiates | → Buy | |||
08/13/2024 | 37.36% | HC Wainwright & Co. | $5 → $5 | Reiterates | Buy → Buy | |||
08/13/2024 | 9.89% | Needham | $4 → $4 | Reiterates | Buy → Buy | |||
07/30/2024 | 37.36% | HC Wainwright & Co. | $5 → $5 | Reiterates | Buy → Buy | |||
07/25/2024 | 9.89% | Needham | $4 → $4 | Reiterates | Buy → Buy | |||
06/25/2024 | 37.36% | Oppenheimer | → $5 | Initiates | → Outperform | |||
05/13/2024 | 9.89% | Needham | $4 → $4 | Reiterates | Buy → Buy | |||
05/13/2024 | 37.36% | HC Wainwright & Co. | $6 → $5 | Maintains | Buy | |||
04/11/2024 | 9.89% | Needham | — | $4 → $4 | Reiterates | Buy → Buy | ||
03/14/2024 | 64.84% | HC Wainwright & Co. | $6 → $6 | Reiterates | Buy → Buy | |||
03/13/2024 | 9.89% | Needham | $4 → $4 | Reiterates | Buy → Buy | |||
03/13/2024 | 37.36% | JMP Securities | $5 → $5 | Reiterates | Market Outperform → Market Outperform | |||
03/13/2024 | 9.89% | Wedbush | $5 → $4 | Maintains | Outperform | |||
11/14/2023 | 64.84% | HC Wainwright & Co. | → $6 | Reiterates | Buy → Buy | |||
11/06/2023 | 64.84% | HC Wainwright & Co. | → $6 | Reiterates | Buy → Buy | |||
08/15/2023 | 37.36% | JMP Securities | → $5 | Reiterates | Market Outperform → Market Outperform | |||
08/15/2023 | 64.84% | HC Wainwright & Co. | → $6 | Reiterates | Buy → Buy | |||
08/15/2023 | 9.89% | Needham | → $4 | Reiterates | Buy → Buy | |||
07/19/2023 | 64.84% | HC Wainwright & Co. | → $6 | Reiterates | Buy → Buy | |||
07/12/2023 | 37.36% | JMP Securities | → $5 | Reiterates | Market Outperform → Market Outperform | |||
07/10/2023 | 64.84% | HC Wainwright & Co. | → $6 | Reiterates | Buy → Buy | |||
06/14/2023 | 64.84% | JonesTrading | → $6 | Initiates | → Buy | |||
06/01/2023 | 64.84% | HC Wainwright & Co. | → $6 | Reiterates | Buy → Buy | |||
05/12/2023 | 64.84% | HC Wainwright & Co. | → $6 | Reiterates | Buy → Buy | |||
04/28/2023 | 64.84% | JMP Securities | → $6 | Reiterates | → Market Outperform | |||
04/20/2023 | 9.89% | Needham | → $4 | Reiterates | → Buy | |||
04/19/2023 | 64.84% | HC Wainwright & Co. | → $6 | Reiterates | → Buy | |||
03/10/2023 | 64.84% | JMP Securities | $7 → $6 | Maintains | Market Outperform | |||
03/10/2023 | 64.84% | HC Wainwright & Co. | → $6 | Reiterates | → Buy | |||
03/10/2023 | 9.89% | Needham | $5 → $4 | Maintains | Buy | |||
02/13/2023 | 92.31% | JMP Securities | → $7 | Reiterates | → Market Outperform | |||
02/03/2023 | 37.36% | Needham | → $5 | Reiterates | → Buy | |||
11/10/2022 | 119.78% | Stifel | → $8 | Upgrade | Hold → Buy | |||
11/10/2022 | 37.36% | Needham | → $5 | Upgrade | Hold → Buy | |||
11/10/2022 | 64.84% | HC Wainwright & Co. | $5 → $6 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Clearside Biomedical (CLSD)?
El último precio objetivo de Clearside Biomedical (NASDAQ:CLSD) fue comunicado por Chardan Capital el julio 18, 2025. La firma de analistas fijó un precio objetivo para $0.00 que espera CLSD a fall dentro de 12 meses (un posible -100.00% downside). 16 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Clearside Biomedical (CLSD)?
La última calificación de analistas para Clearside Biomedical (NASDAQ:CLSD) fue proporcionada por Chardan Capital, y Clearside Biomedical rebajado su neutral calificación.
¿Cuándo se produjo la última revisión al alza de Clearside Biomedical (CLSD)?
La última revisión al alza de Clearside Biomedical Inc se produjo en noviembre 10, 2022, cuando Stifel elevó su precio objetivo a $8. Stifel anteriormente tenía a hold para Clearside Biomedical Inc.
¿Cuándo fue la última revisión a la baja de Clearside Biomedical (CLSD)?
La última revisión a la baja de Clearside Biomedical Inc se produjo en julio 18, 2025, cuando Chardan Capital cambió su precio objetivo de N/A a N/A para Clearside Biomedical Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Clearside Biomedical (CLSD)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Clearside Biomedical, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Clearside Biomedical se registró el julio 18, 2025, por lo que la próxima calificación estará disponible en torno al julio 18, 2026.
¿Es correcta la calificación de los analistas sobre Clearside Biomedical (CLSD)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Clearside Biomedical (CLSD) fue un rebajado con un precio objetivo de $0.00 a $0.00. El precio actual al que cotiza Clearside Biomedical (CLSD) es de $3.64, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.